HYDERABAD/BENGALURU Jan 31 (Reuters) - Sun Pharmaceutical, India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided by strong sales in the domestic market. The Mumbai-based firm's consolidated net profit rose 15% to 29.03 billion rupees ($335.3 million) in third quarter, beating analysts' average estimate of 28.81 billion rupees, according to data compiled by LSEG. ($1 =...

04:36 AM EST, 01/31/2025 (MT Newswires) -- Maze Therapeutics (MAZE) said late Thursday it priced its upsized initial public offering of about 8.8 million shares at $16 per share for gross proceeds of $140 million. In addition, Maze Therapeutics said it has granted the underwriters a 30-day option to purchase up to an additional 1.3 million shares of common stock...

04:55 AM EST, 01/31/2025 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) said Friday it has made a reimbursement agreement with National Health Service England for eligible sickle cell disease patients to access the CRISPR/Cas9 gene-edited therapy, Casgevy. The reimbursement agreement coincides with the UK National Institute for Health and Care Excellence recommending Casgevy's use by the NHS, the company...

04:44 AM EST, 01/31/2025 (MT Newswires) -- Viper Energy ( VNOM ) said Thursday it has priced an expanded public offering of 24.6 million Class A common shares at $44.5 per share, increasing by 2.6 million shares compared to the initial plan. Underwriters have a 30-day option to buy up to 3.7 million extra shares at the offering price, the...